We believe that the 11 genes, especially CARD6, NLRP2, OBSCN, and USP40, could be used as useful diagnostic, prognostic, and therapeutic markers in ccRCC. This evidence concerns the gene OBSCN and nonpapillary renal cell carcinoma.